BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11549475)

  • 1. Pilot trial of bacterial interference for preventing urinary tract infection.
    Darouiche RO; Donovan WH; Del Terzo M; Thornby JI; Rudy DC; Hull RA
    Urology; 2001 Sep; 58(3):339-44. PubMed ID: 11549475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter randomized controlled trial of bacterial interference for prevention of urinary tract infection in patients with neurogenic bladder.
    Darouiche RO; Green BG; Donovan WH; Chen D; Schwartz M; Merritt J; Mendez M; Hull RA
    Urology; 2011 Aug; 78(2):341-6. PubMed ID: 21683991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial interference for prevention of urinary tract infection: a prospective, randomized, placebo-controlled, double-blind pilot trial.
    Darouiche RO; Thornby JI; Cerra-Stewart C; Donovan WH; Hull RA
    Clin Infect Dis; 2005 Nov; 41(10):1531-4. PubMed ID: 16231269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Original strategy for prevention of recurrent symptomatic urinary tract infections in patients with neurogenic bladder: Bacterial interference, state of the art].
    Falcou L; Davido B; Even A; Bouchand F; Salomon J; Sotto A; Denys P; Dinh A
    Prog Urol; 2018 May; 28(6):307-314. PubMed ID: 29699855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bacterial interference strategy for prevention of UTI in persons practicing intermittent catheterization.
    Prasad A; Cevallos ME; Riosa S; Darouiche RO; Trautner BW
    Spinal Cord; 2009 Jul; 47(7):565-9. PubMed ID: 19139758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased microbiota diversity associated with urinary tract infection in a trial of bacterial interference.
    Horwitz D; McCue T; Mapes AC; Ajami NJ; Petrosino JF; Ramig RF; Trautner BW
    J Infect; 2015 Sep; 71(3):358-367. PubMed ID: 26048203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients.
    Hull R; Rudy D; Donovan W; Svanborg C; Wieser I; Stewart C; Darouiche R
    J Urol; 2000 Mar; 163(3):872-7. PubMed ID: 10687996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial interference for prevention of urinary tract infection: an overview.
    Darouiche RO; Hull RA
    J Spinal Cord Med; 2000; 23(2):136-41. PubMed ID: 10914355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model.
    Jakobsen L; Cattoir V; Jensen KS; Hammerum AM; Nordmann P; Frimodt-Møller N
    J Antimicrob Chemother; 2012 Oct; 67(10):2438-44. PubMed ID: 22685162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women.
    Beerepoot MA; ter Riet G; Nys S; van der Wal WM; de Borgie CA; de Reijke TM; Prins JM; Koeijers J; Verbon A; Stobberingh E; Geerlings SE
    Arch Intern Med; 2011 Jul; 171(14):1270-8. PubMed ID: 21788542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of urinary tract infection in spinal cord-injured patients: safety and efficacy of a weekly oral cyclic antibiotic (WOCA) programme with a 2 year follow-up--an observational prospective study.
    Salomon J; Denys P; Merle C; Chartier-Kastler E; Perronne C; Gaillard JL; Bernard L
    J Antimicrob Chemother; 2006 Apr; 57(4):784-8. PubMed ID: 16473921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial interference--is deliberate colonization with Escherichia coli 83972 an alternative treatment for patients with recurrent urinary tract infection?
    Sundén F; Håkansson L; Ljunggren E; Wullt B
    Int J Antimicrob Agents; 2006 Aug; 28 Suppl 1():S26-9. PubMed ID: 16843646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escherichia coli 83972 bacteriuria protects against recurrent lower urinary tract infections in patients with incomplete bladder emptying.
    Sundén F; Håkansson L; Ljunggren E; Wullt B
    J Urol; 2010 Jul; 184(1):179-85. PubMed ID: 20483149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model.
    Vellinga A; Tansey S; Hanahoe B; Bennett K; Murphy AW; Cormican M
    J Antimicrob Chemother; 2012 Oct; 67(10):2523-30. PubMed ID: 22729920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance Patterns of Escherichia coli in Women with Uncomplicated Urinary Tract Infection Do Not Correlate with Emergency Department Antibiogram.
    Hines MC; Al-Salamah T; Heil EL; Mallemat H; Witting MD; Johnson JK; Winters ME; Hayes BD
    J Emerg Med; 2015 Dec; 49(6):998-1003. PubMed ID: 26281821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic resistance in E. coli isolates from patients with urinary tract infections presenting to the emergency department.
    Hitzenbichler F; Simon M; Holzmann T; Iberer M; Zimmermann M; Salzberger B; Hanses F
    Infection; 2018 Jun; 46(3):325-331. PubMed ID: 29368165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women.
    Beerepoot MA; ter Riet G; Nys S; van der Wal WM; de Borgie CA; de Reijke TM; Prins JM; Koeijers J; Verbon A; Stobberingh E; Geerlings SE
    Arch Intern Med; 2012 May; 172(9):704-12. PubMed ID: 22782199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot randomized double-blind placebo-controlled trial on the use of antibiotics on urinary catheter removal to reduce the rate of urinary tract infection: the pitfalls of ciprofloxacin.
    Wazait HD; Patel HR; van der Meulen JH; Ghei M; Al-Buheissi S; Kelsey M; Miller RA; Emberton M
    BJU Int; 2004 Nov; 94(7):1048-50. PubMed ID: 15541126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition.
    Smith SP; Manges AR; Riley LW
    Clin Infect Dis; 2008 Mar; 46(5):689-95. PubMed ID: 18230040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.